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Arrhythmogenic right ventricular dysplasia/ 
/cardiomyopathy (ARVD/C) is a genetically deter-
mined heart muscle disorder that is characterized 
pathologically by fibrofatty replacement of the right 
ventricular (RV) myocardium. The clinical diagno-
sis of ARVD/C is complex, since there is no single 
diagnostic “gold standard”. The diagnosis is based 
on major and minor criteria that have been modified 
and take into account heart structure and func-
tion, family history, genetic mutations, histology, 
ventricular arrhythmias, and electrocardiographic 
abnormalities [1].
Diagnostic imaging criteria include regional 
RV wall motion abnormalities in combination with 
RV dilatation or global RV systolic dysfunction 
[1]. Conventional echocardiography is capable 
of detecting these changes in the RV, consisting 
of visual regional wall motion analyses, outflow 
tract dimensions and RV-fractional area change, 
and remains part of the current diagnostic Task 
Force criteria [1].
However, a comprehensive and accurate 
evaluation of the RV by echocardiography is 
technically challenging due to the retrosternal 
position and complex geometry of the RV. Cardiac 
magnetic resonance (CMR) imaging has revolu-
tionized the diagnostic accuracy for ARVD/C and 
found to be of superior value compared to conven-
tional echocardiography [2]. Pathologies causing 
RV volume overload such as intracardiac shunts 
(e.g. atrial septal defects, anomalous pulmonary 
venous drainage) can be misinterpreted as pos-
sible ARVD/C on standard echocardiography [3], 
and we often depend on CMR for a more definitive 
diagnosis.
Although the role of echocardiography ver-
sus CMR in ARVD/C is subject to debate, it still 
remains the initial screening modality that can 
provide the first clue towards the diagnosis. In 
addition, CMR is often not feasible for the peri-
odic follow-up of ARVD/C due to the high rate 
of implantable cardioverter-defibrillator (ICD) 
implantation and the relative high cost. There 
have been recent advances in echocardiography 
with the availability of novel techniques such as 
3 dimensional right ventricular (3D-RV) imaging 
and tissue deformation imaging. These methods 
could improve the diagnostic and prognostic per-
formance of echocardiography in these patients.
In this issue of ”Cardiology Journal”, Mast et 
al. [4] describe the current and future role of both 
conventional and new echocardiographic param-
eters in ARVD/C with respect to diagnosis and 
follow-up. The authors provide an ARVD/C focused 
echocardiographic protocol which is currently 
in use in their institution. They discuss 3D-RV 
imaging which enables more accurate RV volu-
metric measurements compared to conventional 
echocardiography [5]. With the implementation 
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dysfunction can be seen in ARVD/C, and can con-
tribute to early diagnosis [6].
The article also discusses the utility of tissue 
deformation imaging which can accurately detect 
subtle RV regional wall motion abnormalities and 
mechanical dyssynchrony [7, 8]. RV myocardial 
tissue deformation results primarily in longitu-
dinal systolic shortening. The ability to quantify 
regional wall motion rather than visual qualita-
tive assessment is a critical advantage of tissue 
deformation imaging compared to conventional 
echocardiographic wall motion analysis. The diag-
nostic performance of peak systolic strain has been 
found to be superior to conventional measurements 
in ARVD/C patients [9]. Both multiplane- and 
3D-speckle measurement of tracking are promis-
ing new applications in RV deformation imaging, 
but require further validation before widespread 
clinical implementation. Measurements of dys-
synchrony could provide evidence of early, subtle 
electrical disturbances in ARVD/C, and may further 
improve the diagnostic value of echocardiography 
[8, 10].
The accurate diagnosis of ARVD/C is critically 
important because the diagnosis carries a risk of 
sudden cardiac death. An incorrect diagnosis can 
lead to unnecessary insertion of an ICD, cause 
a psychosocial burden, and initiate costly and 
extensive screening of family members, with the 
possibility of overdiagnosis due to inaccurate in-
terpretation of tests performed during screening 
[11]. The article by Mast et al. [4] suggests that 
the novel robust parameters derived from 3D-RV 
echocardiography and tissue deformation imaging, 
has incremental diagnostic value and could change 
the current diagnostic role of echocardiography in 
ARVD/C.
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